![Thorsten P. Degenhardt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thorsten P. Degenhardt
Operationeel Directeur bij Mycovia Pharmaceuticals, Inc.
Actieve functies van Thorsten P. Degenhardt
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Mycovia Pharmaceuticals, Inc.
![]() Mycovia Pharmaceuticals, Inc. BiotechnologyHealth Technology Mycovia Pharmaceuticals, Inc. develops novel drugs in areas of unmet medical need, with an initial focus in women?s health. Its product candidate, VT-1161, engages in developed as a treatment for recurrent vulvovaginal candidiasis. The company was founded in 2018 and is headquartered in Durham, NC. | Operationeel Directeur | - | - |
Loopbaan van Thorsten P. Degenhardt
Eerdere bekende functies van Thorsten P. Degenhardt
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BioStratum, Inc.
![]() BioStratum, Inc. Pharmaceuticals: MajorHealth Technology BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC. | Corporate Officer/Principal | - | - |
University of South Carolina | Corporate Officer/Principal | - | - |
Cempra Pharmaceuticals, Inc.
![]() Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | Corporate Officer/Principal | 28-04-2009 | - |
Opleiding van Thorsten P. Degenhardt
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Technische Universität Darmstadt | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Duitsland | 3 |
Operationeel
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Cempra Pharmaceuticals, Inc.
![]() Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | Health Technology |
BioStratum, Inc.
![]() BioStratum, Inc. Pharmaceuticals: MajorHealth Technology BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC. | Health Technology |
Mycovia Pharmaceuticals, Inc.
![]() Mycovia Pharmaceuticals, Inc. BiotechnologyHealth Technology Mycovia Pharmaceuticals, Inc. develops novel drugs in areas of unmet medical need, with an initial focus in women?s health. Its product candidate, VT-1161, engages in developed as a treatment for recurrent vulvovaginal candidiasis. The company was founded in 2018 and is headquartered in Durham, NC. | Health Technology |